Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03078491 · ClinicalTrials.gov registry record · NA
Technological Advances in Glucose Management in Older Adults
A NA study of Type 1 Diabetes Mellitus and Hypoglycemia, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
- 1
- Study location
NCT03078491 is a NA study of Type 1 Diabetes Mellitus and Hypoglycemia that has completed, run by Joslin Diabetes Center. The registered enrollment target is 168 participants, above the 139-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03078491, a NA study of Type 1 Diabetes Mellitus and Hypoglycemia, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to assess the effectiveness of CGM (Continuous Glucose Monitor), enhanced by a diabetes management platform (DMP), collectively called enhanced CGM (eCGM), in the care of older patients with T1D. The DMP includes an automated data transfer from CGM, insulin-delivery devices, and activity tracker to a clinical decision support system (CDS) that provides dosing adjustment recommendations based on that data to the healthcare team. In addition, the DMP includes on-demand education for patients and caregivers, and an interface for communication between providers, patients, and their caregivers.
Conditions Studied
Interventions
- OTHER eCGM (enhanced CGM)
Study Locations (1)
Massachusetts
- Joslin Diabetes Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2017-03-30 |
| Est. Completion | 2022-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03078491
The ClinicalTrials.gov registry entry for NCT03078491 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 139-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (21% higher). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which eCGM (enhanced CGM) is the first listed.
NCT03078491 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03078491 about?
NCT03078491 is a clinical study titled "Technological Advances in Glucose Management in Older Adults". This is a study to assess the effectiveness of CGM (Continuous Glucose Monitor), enhanced by a diabetes management platform (DMP), collectively called enhanced CGM (eCGM), in the care of older patients with T1D. The DMP includes an automated data transfer from CGM, insulin-delivery devices, and acti...
What is the current status of trial NCT03078491?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2017-03-30. Estimated completion is 2022-10-01.
What conditions does trial NCT03078491 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus, Hypoglycemia, Older Adults.
What interventions are being tested in trial NCT03078491?
The interventions under investigation include: eCGM (enhanced CGM) (OTHER).
Who is sponsoring clinical trial NCT03078491?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03078491 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.